AI Summary

A study published online on Oct. 5 in JAMA Internal Medicine found that patients with inflammatory arthritis who pause certain disease‑modifying antirheumatic drugs—specifically selected biologic agents or Janus kinase inhibitors—for two weeks around a supplemental COVID‑19 vaccine dose do not see an improvement in humoral immune response. The research examined the effect of this pause on antibody production following the vaccine. The findings suggest that withholding these therapies does not enhance vaccine‑induced antibody levels.

AI summaries can be wrong sometimes—always verify important details using the source article.